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PR E S S U R E U L C E R S A R E S T I L L Av e ry common problem inhospitalized patients. In2006, 8% of hospitalized
patients in the Netherlands had a
p re s s u re ulcer grade II or worse
(Halfens, Janssen, & Meijers,
2006). The pro p o rtion of newly
hospitalized patients developing
p re s s u re ulcers varied from 2.7%
to 29.5%, depending on the popu-
lation studied (Schoonhoven,
Bousema, & Buskens, 2007). In
one study it was estimated that
about 40% of patients hospital-
ized for more than 5 days quali-
fied for preventive measure s
(Schoonhoven et al., 2006).
P re s s u re ulcers are caused by
p re s s u re and shearing forc e s
( D e f l o o r, 1999; Defloor et al.,
2004). Clinical guidelines describe
various measures for pre v e n t i n g
and treating pre s s u re ulcers (CBO
Dutch Institute for Health Care
I m p rovement, 2002; National
Institute for Health and Clinical
Excellence, 2003). Effective pre-
ventive measures reduce the
intensity and/or the duration of
p re s s u re and shearing forces. For
this a technical approach can be
used in which the intensity of
p re s s u re and shearing forces are
reduced by pre s s u re - re l i e v i n g
m a t t resses, cushions, and posture s
(CBO, 2002). Altern a t i v e l y, a more
human re s o u rce intensive ap-
p roach (turning, re p o s i t i o n i n g ,
and mobilization) can be used. In
EX E C U T I V E SU M M A RY
The purpose of this study wa s
to determine the cost for pre-
vention and treatment of pres-
sure ulcers from a hospital per-
s p e c t i ve and to identify the
least resource-intensive pres-
sure ulcer prevention stra t e g y.
Cost analyses were ex a m i n e d
from a hospital perspective
using direct costs. The study
was carried out alongside a
p r o s p e c t i ve cohort study on the
incidence and risk factors fo r
pressure ulcers.
Two large teaching hospitals in
the Netherlands with (part l y )
opposing approaches in pre-
vention, a technological ve r s u s
a human approach, were ana-
l y ze d .
The main outcome measures
were resource use, costs of
p r eve n t i ve measures and treat-
ment, and pressure ulcer inci-
dence in both hospitals.
Pressure ulcer preve n t i o n
through a predominantly techni-
cal approach resulted in a simi-
lar incidence rate as preve n t i o n
through a predominantly human
a p p r o a c h .
H oweve r, the technical
approach was considera bly less
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p re s s u re ulcer care these interv e n-
tions are used either as pre v e n t i o n
or in addition to wound tre a t m e n t ,
depending on the actual condition
of the patient’s skin. 
P reventive measures and tre a t-
ment for pre s s u re ulcers are general-
ly considered expensive and labor
intensive. There have been few
attempts to estimate the cost of pre s-
s u re ulcer care (Bennet, Dealey, &
Posnett, 2004; Haalboom, 1991;
S e v e rens, Habraken, Duivenvoord e n ,
& Frederiks, 2002). The most re c e n t
study in the Dutch setting estimat-
ed the cost of illness of pre s s u re
ulcers between $362 million and
$2.8 billion per year (Severens et
al., 2002). All these estimates are ,
h o w e v e r, based on expert opinion
and lack actual basis in terms of
data. 
To date, an economic evalua-
tion re c o rding the use of health
c a re re s o u rces in hospitals for pre-
venting or treating pre s s u re ulcers
is missing in the literature. We car-
ried out an economic evaluation
as part of a large pre s s u re ulcer
p rediction rule validation study.
The aim of this study was (a) to
d e t e rmine the cost for pre v e n t i o n
and treatment of pre s s u re ulcers
f rom a hospital perspective, and
(b) to establish the least re s o u rc e -
intensive pre s s u re ulcer pre v e n-
tion strategy. Specifically, care
with a predominant focus on a
human re s o u rce approach and
c a re with a predominant focus on
a technical approach for pre v e n t-
ing and treating pre s s u re ulcers
w e re examined.
Methods
Sample. This burden of dis-
ease and cost minimization study
was carried out as an adjunct to
the Purse Value study, an observ a-
tional prospective cohort study for
the validation of a newly devel-
oped pre s s u re ulcer pre d i c t i o n
rule. The cost study provided the
data for the cost calculations. The
Purse Value study provided the
data on the incidence of pre s s u re
ulcers and the average number of
days for preventive and tre a t m e n t
c a re necessary to extrapolate cost
data to the hospital level. The data
on prevention of these two studies
w e re combined in the cost mini-
mization analysis.
Purse Value study. The Purse
Value study was an observ a t i o n a l
p rospective cohort study carr i e d
out in two large teaching hospitals
in the Netherlands (the Canisius
Wilhelmina Hospital [CWZ] in
Nijmegen and the St. Antonius
Hospital [SAH] in Nieuwegein),
with a capacity of 653 and 584
beds re s p e c t i v e l y. 
Patients admitted to surg i c a l ,
i n t e rnal, and neurological ward s ,
without pre s s u re ulcers, older
than 18 years, and with an expect-
ed admission of at least 5 days
w e re eligible; a total of 11,000 ful-
filled the criteria during the study
period. Research nurses visited
each ward twice a week and asked
eligible patients admitted in the
past 48 hours to part i c i p a t e .
A p p roximately a quarter of all
potentially eligible patients could
be visited, of whom 1,807 (66%)
a g reed to participate. Eventually,
79.7% patients (1,440) had at least
one followup visit before dis-
c h a rge; 618 patients at SAH
between May 2001 and May 2002,
and 822 patients at CWZ between
May 2003 and March 2004. 
P re s s u re ulcers were graded
a c c o rding to the classification of
the European Pre s s u re Ulcer
A d v i s o ry Panel (1999). The out-
come was defined as occurre n c e
of a pre s s u re ulcer grade 2 or
worse. The nurses on the ward
w e re blinded for the observ a t i o n s
of the re s e a rch nurse. 
Data from this study were
used to calculate the incidence of
p re s s u re ulcers and the average
number of days for pre v e n t i v e
c a re and tre a t m e n t .
Patient characteristics for the
two samples included in this
study are shown in Table 1. The
mean age in both samples does not
d i ffer significantly (64.8 vs. 66
years; p=0.09). However, signifi-
cantly more patients were admit-
ted to the surgical wards in SAH
than in CWZ (87.4% and 36.9%,
respectively), and the length of
stay in CWZ was significantly
longer than in SAH (2.8 and 2.3
weeks, re s p e c t i v e l y, p < 0 . 0 0 0 1 ) .
Yet, a larger part of the SAH sam-
ple was at risk for pre s s u re ulcer
development according to the
clinical prediction rule developed
(Schoonhoven et al., 2006), com-
p a red to the CWZ sample (51%
and 23.5%, re s p e c t i v e l y, p <
0.0001). Most of the other diff e r-
ences are related to the pre v e n t i o n
and treatment approach which
was compared in this study.
M o re o v e r, the incidence of pre s-
s u re ulcers does not differ signifi-
cantly between the two samples
(5.5% and 4.9%, p= 0 . 1 5 ) .
T h e re f o re, we concluded that we
could compare the two samples
and present a cost minimization
analysis. 
Cost study. The cost study was
p e rf o rmed in parallel with the
Purse Value study. Due to specific
sampling of patients who either
received prevention or tre a t m e n t
for an existing pre s s u re ulcer, this
study enrolled other patients than
the Purse Value study. Patients
remained in the study until dis-
continuation of preventive meas-
u res, until the pre s s u re ulcer was
healed, or until discharge or death
of the patient. Between October
2001 and Febru a ry 2002, 120
(n=94 prevention group, n=26
t reatment group) patients in SAH,
and between November 2003 and
J a n u a ry 2004, 130 (n=65 pre v e n-
tion group, n=65 treatment gro u p )
patients in the CWZ were includ-
ed. In CWZ ten patients in the pre-
vention group and seven in the
t reatment group were excluded
f rom the final analysis because of
incomplete data. Ultimately, 149
patients with complete data were
available in the prevention gro u p
and 84 patients in the tre a t m e n t
g roup (see Table 2 & Figure 1).
Data collection. I n d i v i d u a l
patient characteristics and pre s-
s u re ulcer related re s o u rce use
w e re gathered on a standard i z e d
case re p o rt form (CRF). The nurs-
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ing staff filled out the CRF at the
s t a rt of prevention or tre a t m e n t
and subsequently once a week
until prevention or treatment was
discontinued or when the patient
was discharged or died. If pre v e n-
tion or treatment changed during
the observation period, the date of
change was noted and a new CRF
was filled out. The data from the
CRF consisted of 180 items. The
daily re s o u rce use re c o rded by the
nursing staff using the CRF con-
sisted of time spent by the nursing
s t a ff, use of materials, therapeutic
i n t e rventions (e.g., necro t o m y ) ,
enteral nutrition, and consulta-
tions of a specialized wound care
* Calculated on total of 1,274 patient week records for St. Antonius Hospital (SAH) and 2,104 patient week records for Canisius
Wilhelmina Hospital (CWZ).
† Score ranges from 0 to 41 points. > 20 points is considered at ri s k .
PU = pressure ulcer
t=students t-test; 2 = Chi-square test; U = z-value Mann W h i t n ey U test
Table 1.
Characteristics Patient Groups in Purse Value Study per Hospital
S A H
(n=618 patients/
9,912 patient day s )
CWZ 
(n=822 patients/ 
16,254 patient day s ) Test Statistic p Va l u e
Age (mean, SD) 64.8 ( 1 2 . 6 ) 66 ( 1 4 . 8 ) t - 1 . 6 9 0 . 0 9
Female (n,%) 268 ( 4 3 . 4 % ) 428 ( 5 2 . 1 % ) 2 1 0 . 6 9 0 . 0 0 1
Ward (n,%)
S u r g i c a l
I n t e rn a l
N e u r o l o g y
540 ( 8 7 . 4 % )
59 ( 9 . 5 % )
19 ( 3 . 1 % )
303 ( 3 6 . 9 % )
457 ( 5 5 . 6 % )
62 ( 7 . 5 % )
2 3 7 5 . 0 7 <0 . 0 0 0 1
Length of stay in days (mean, sd) 16.4 ( 6 . 8 ) 19.8 ( 1 0 . 6 ) t - 7 . 4 2 <0 . 0 0 0 1
C u mu l a t i ve incidence
PU grade II or worse (n, %)
34 ( 5 . 5 % ) 40 ( 4 . 9 % ) 2 2 . 1 0 0 . 1 5
Incidence rate PU grade II or worse per
patient week (mean, SD)
0.03 ( 0 . 1 6 ) 0 . 0 2 ( 0 . 1 3 ) t 1 . 3 9 0 . 1 6
Number of patients receiving preve n t i o n 4 5 3 1 2 9 U - 1 . 8 1 <0 . 0 0 0 1
Mean days (SD) of preve n t i o n 10.7 ( 4 . 6 ) 13.4 ( 9 . 4 ) t - 3 . 1 9 0 . 0 0 2
Score on prePURSE scale (mean, SD) *† 18.1 ( 8 . 7 ) 13.3 ( 7 . 5 ) t 1 7 . 7 1 <0 . 0 0 0 1
At risk according to prePURSE scale (no
of patient we e k s,%) * †
650 ( 5 1 % ) 4 9 5 ( 2 3 . 5 % ) 2 2 2 3 . 5 6 <0 . 0 0 0 1
* Figures do not represent prevalence or incidence because patients were selected based on presence of pressure ulcers.
SAH = St Antonius Hospital; CWZ = Canisius Wilhelmina Hospital
Table 2.
Characteristics of Patient Groups in Cost Study per Hospital
S A H
( n = 1 2 0 )
CWZ 
( n = 1 1 3 )
To t a l
( n = 2 3 3 ) p Va l u e
A g e, mean (SD) in prevention group (n=149) 68 (14.8) 75 (11.9) 71 (14) <0 . 0 0 1
A g e, mean (SD) in treatment group (n=84) 76 (13.1) 78 (10.9) 77 (12) 0 . 0 5
Pressure ulcers per gra d e *
G rade I (n) 6 1 1
G rade II (n) 1 6 2 2
G rade III (n) 3 1 2
G rade IV (n) 1 1 3
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nurse, dietician, or medical spe-
cialist. The 180 items were catego-
rized into four main topics: costs
for repositioning, costs for mobi-
lization, costs for wound care, and
costs for re s o u rces (special beds,
m a t t resses, dressings, nutritional
supplements, ointments). 
Cost calculation methods. T h e
hospital perspective used in this
study compares direct costs (not
c h a rges or reimbursed amounts) of
p redominantly technical and pre-
dominantly human approaches to
p revention and treatment of pre s-
s u re ulcers (Oostenbrink, Buijs-
Van der Woude, van Agthoven,
Koopmanschap, & Rutten, 2003).
The costs of the pre s s u re ulcer
i n t e rventions were determ i n e d
using the bottom-up method, in
which costs are calculated by di-
rectly tracing re s o u rces (Oostenbrink,
Koopmanschap, & Rutten, 2002).
The standard mattresses used in
both hospitals were high-quality
p re s s u re - reducing foam mattre s s-
es (the Cliniplot mattress [Hill-
Rom, U.S.] in the SAH and the
Te m p u r-Pedic viscoelastic foam
m a t t ress [Te m p u r-Pedic, U.S.] in
the CWZ). Table 3 gives an
o v e rview of the data that were col-
lected for the calculation of the
d i rect costs. 
Cost outcomes include cost
per intervention, cost of pre v e n-
tion, cost of treatment, cost per
d a y, and cost per patient re c e i v i n g
p revention or treatment. Sub-
s e q u e n t l y, we estimated the annu-
al expenditures for the Dutch
national health system by extrapo-
lating from previously published
national admission data and data
on prevalence of pre s s u re ulcers. 
Cost per interv e n t i o n . For the
analysis of the average daily cost
per intervention, the unit price per
item scored on the CRF was estab-
lished first (see Table 3). Hospital
p u rchase prices of wound care
p roducts, enteral nutrition, spe-
cial beds, and mattresses were
obtained from the hospitals (unit
prices reflect mean purchase cost
after negotiation). The hour/
minute wages of wound care nurs-
es, dieticians, medical specialists,
and nursing staff were in accor-
dance with Dutch standard s
(Oostenbrink et al., 2003). These
wages re p resent the total of the
health care worker costs to the
o rganization, including benefits.
The overall cost for each inter-
vention was calculated using the
following methodology. The time
input of personnel was multiplied
by the average wage costs per
minute for each specific staff cate-
g o ry. The costs of materials were
calculated by multiplying the
average volume per article by the
unit price. This resulted in the
cost per intervention (costs for
repositioning, costs for mobiliza-
tion, costs for wound care, and
costs for re s o u rces [special beds,
m a t t resses, dressings, nutritional
supplements, ointments]). 
Patients were not admitted to
the hospital for treatment or pre-
vention of pre s s u re ulcers.
T h e re f o re the indirect costs (e.g.,
patient transport, central heating,
and costs of basic health care such
as the standard bed and mattre s s )
w e re not taken into account.
These costs do not seem attributa-
ble to pre s s u re ulcer care .
Cost of pre v e n t i o n . The over-
all cost for prevention in each hos-
pital was calculated by adding the
costs of the diff e rent interv e n t i o n s
used for prevention (re p o s i t i o n-
ing, mobilization, and re s o u rc e s ) .
Cost of tre a t m e n t . The overall
cost for treatment in each hospital
was the sum of the cost of the diff e r-
ent interventions for tre a t m e n t
( repositioning, mobilization, wound
c a re, and re s o u rces). As these costs
i n c rease with the severity of the
p re s s u re ulcer, cost per pre s s u re
ulcer grade was calculated separate-
l y.
Cost per day. For establishing
the average cost per day, the total
cost for prevention and tre a t m e n t
in the period of care calculated in
the cost study was divided by the
number of pre s s u re ulcer pre v e n-
tion or treatment days observed in
the cost study. 
For establishing the average
cost per grade per day, the total
cost for treatment per grade in the
Figure 1.
Flowchart of Patient Inclusion Cost Study
E x c l u s i o n
due to
i n c o m p l e t e
data: 10
p a t i e n t s
E x c l u s i o n
due to
i n c o m p l e t e
data: 7
p a t i e n t s
Complete date
p r ev e n t i o n
149 patients
(94 SAH; 55 CWZ)
Complete data 
t r e a t m e n t
84 patients
(26 SAH; 48 CWZ)
250 patients
P r ev e n t i o n
159 patients
(94 SAH; 65 CWZ)
Tr e a t m e n t
91 patients
(26 SAH; 65 CWZ)
SAH = St. Antonius Hospital; CWZ = Canisius Wilhelmina Hospital
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N OT E : Hospital purchase prices of wound care products, enteral nu t rition, special beds, and mattresses were obtained from
the hospitals (unit prices reflect mean purchase cost after negotiation).
* Price depends on brand, size or type of product, multiple bra n d s, size s, or types used.
Table 3.
Information Was Gathered on the Direct Costs
I t e m D e s c r i p t i o n Cost in €
M a t t r e s s e s Cost per Day (min-max)*
Standard mattress -
Foam mattress 2
Gel ove rl ay mattress 1 2
Air mattress 6
L ow air loss mattress 1 8
A l t e rnating pressure mattress 1 1
C o n t i nuous low pressure mattress 16 - 30
Air fluidize d 5 4
O t h e r 1 8




O t h e r 2
Wound care products Cost per Piece (min-max)*
G a u ze 0.03 - 0.52 
Hydrocolloid dressing 2.98 - 22.97
Cleansing dressing 0.27 - 3.99
Silicone dressing 0.85 - 6.32
Absorbent dressing 0.07 - 0.33
Transparent film dressing 0.33 - 4.82
B a n d a g e 0.36 - 3.10
G l ove s 0 . 1 0
C a t h e t e r 0 . 1 4
S y ringe 50 ml 0 . 4 6
NaCl fluid 0 . 0 1
S t e rile cup 0 . 9 5
Twe e ze r 0 . 4 1
A p r o n 0 . 6 0
S c i s s o r 0 . 4 9
O i n t m e n t 0.03 - 0.15 per ml
E n t e ral nu t ri t i o n
S u p p l e m e n t s 1.45 - 6.14 per 200 ml
Tube fe e d i n g 6.28 - 10.03 per 200 ml
Additional thera py Vacuum-assisted closure thera py 45 per day
S a l a ry costs Cost per Minu t e
Nurse daytime only 0 . 4 7
Nurse including nightshift 0 . 5 8
D i e t i c i a n 0 . 5 8
S p e c i a l i zed wound care nu r s e 0 . 5 2
Medical specialist 2 . 4 0
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period of care calculated in the
cost study was divided by the
number of pre s s u re ulcer tre a t-
ment days observed in the cost
s t u d y. 
Cost per patient per hospital
receiving prevention or tre a t m e n t .
These costs per day were extrapo-
lated to mean cost per patient
receiving prevention or tre a t m e n t
per hospitalization period by mul-
tiplying them with the mean num-
ber of prevention or tre a t m e n t
days from the Purse Value study
(see Table 1). 
By multiplying the cost per
grade per day with the mean days
of treatment per grade, the m e a n
total cost for treatment per grade
was calculated. It was not possible
to determine the length of hospi-
talization for grade IV pre s s u re
ulcers patients because grade IV
p re s s u re ulcer did not occur de
novo in the Purse Value study. We
assumed that the number of tre a t-
ment days for grade IV pre s s u re
ulcers was equal to the number of
t reatment days for grade III pre s-
s u re ulcers. Also, the eff e c t i v e n e s s
of the treatment could not be
d e t e rmined as we did not follow
patients until the pre s s u re ulcer
h e a l e d .
Annual national cost. The
c u rrency used is Euros (€); 1 €
equals $1.27 in U.S. dollars. Based
on a previous study, it was
hypothesized that 40% of patients
hospitalized for more than 5 days
a re at risk according to the
p rePURSE risk assessment scale
and there f o re qualify for pre s s u re
ulcer prevention (Schoonhoven et
al., 2006). This percentage was
used as a basis for calculating pre-
vention cost. To estimate the
national annual cost associated
with treating pre s s u re ulcers, the
data on hospitalization and pre v a-
lence of pre s s u re ulcers fro m
Dutch databases were used
(Centraal Bureau voor de
Statistiek [CBS], 2008; Halfens et
al., 2006). Hospitalizations in psy-
chiatric wards were not taken into
account. We assumed that the
mean length of stay of patients
with a pre s s u re ulcer is re p re s e n-
tative for all hospitals and used it
as a basis for calculating tre a t m e n t
cost. 
Cost minimization analysis.
As the incidence of pre s s u re
ulcers did not differ significantly
between the two samples (the
e ffect of the prevention appro a c h-
es on pre s s u re ulcer occurrence is
equal), a cost minimization analy-
sis was perf o rmed. Unfort u n a t e l y,
we do not have data on the eff e c-
tiveness of treatment as this was
not the focus of the Purse Va l u e
s t u d y. There f o re, we only per-
f o rmed a cost minimization analy-
sis for prevention. 
Scenario analysis. N u r s i n g
time is an important component
in the cost of pre s s u re ulcer care
when a predominantly human
a p p roach is used. A scenario
analyses was perf o rmed on the
national costs in which we varied
the cost of nursing time (from 0.5
to 1.5 times the real cost) to
e x p l o re the effect of this variable
on total cost. 
Material costs are an impor-
tant component in the cost of pre s-
s u re ulcer care when a pre d o m i-
nantly technical approach is used.
T h e re f o re, we also calculated dif-
f e rent scenarios in which we var-
ied these cost (50% more and 50%
less than real cost) to explore the
e ffect of this variable on total cost.
F i n a l l y, the number of patients
who are considered at risk deter-
mine the cost of prevention. When
using a validated pre s s u re ulcer risk
assessment scale, 40% of the
patients are estimated to be at risk.
H o w e v e r, in practice this perc e n t-
age may be lower or higher depend-
ing on the risk assessment scale
used (Schoonhoven et al., 2002;
Va n d e rwee, Grypdonck, & Defloor,
2007). T h e re f o re, we also calculat-
ed the national cost for the s c e-
nario in which 30% of the patients,
comparable to the Braden scale, or
70% of the patients, comparable to
the Waterlow scale, are considere d
at risk (Schoonhoven et al., 2002).
Statistical analysis. S t u d e n t ’s
t test or Mann-Whitney U-test
w e re used for continuous data.
The chi-square test or Fisher’s
exact test was used for categorical
data. All data were analyzed using
SPSS 13.0 (SPSS®, Inc., Chicago,
I L ) .
Ethical issues. Ethical ap-
p roval was obtained from the eth-
ical committees of both hospitals.
Individual informed consent was
† Technical approach
SAH = St. Antonius Hospital; CWZ = Canisius Wilhelmina Hospital
Table 4.
Prevention and Treatment of Pressure Ulcers in the Hospitals
S A H C W Z
Applied n (%) Applied n (%)
P r ev e n t i o n n = 9 4 n = 5 5
Special mattress † 24 (26) 25 (46)
R e p o s i t i o n i n g 3   (3) 30 (55)
M o b i l i z a t i o n 45 (48) 34 (62)
Dressing/Ointment † 42 (45) 14 (26)
Tr e a t m e n t n = 2 6 n = 5 8
Special mattress † 22 (85) 31 (53)
R e p o s i t i o n i n g 6 (23) 36 (62)
M o b i l i z a t i o n 19 (73) 44 (76)
Dressing/Ointment † 12 (46) 19 (33)
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obtained from all study part i c i-
pants who volunteered to take
p a rt in the study. Anonymity and
confidentiality were maintained
t h roughout the study.
Results
Incidence of pressure ulcers.
Seventy-four patients developed
a pressure ulcer grade II or worse
in the Purse Value study. The
incidence figures did not differ
significantly between the two
hospitals: 5.5% in SAH and 4.9%
in CWZ (χ2=2.10, df=1; p=0.15)
(see Table 1).
P re s s u re ulcer prevention and
t re a t m e n t . Table 4 shows the
application of diff e rent measure s
of pre s s u re ulcer prevention and
t reatment in the two hospitals.
Although both hospitals applied
p revention according to the Dutch
guidelines (CBO, 2002), the pre-
ventive approach diff e red be-
tween the hospitals. The CWZ
placed most emphasis on re p o s i-
tioning and mobilization (human
a p p roach), while the SAH most fre-
quently used special dressings and
ointments (technical approach).
The same diff e rence was observ e d
in the t re a t m e n t of pre s s u re
ulcers. The SAH placed most
emphasis on special mattre s s e s ,
while the CWZ placed more
emphasis on repositioning. Both
hospitals also frequently mobi-
lized their patients.
Cost of prevention. The mean
cost for the technical approach of
p revention per day was €13 (95%
CI: €8 -€18, range €0 . 5 4 -€103) and
€24 (95% CI: €1 7 -€30; range €0 . 1 3 -
€166) for the human approach (see
Table 5 & Figure 2). The minimum
values re p resent cases in which
only ointment was applied. The
maximum values re p resent pa-
tients who where extensively
mobilized and re p o s i t i o n e d .
F i g u re 2 shows that the larg e s t
p a rt of the costs in the human
a p p roach was composed of cost
for nursing time (€16.27 [67.9%])
( t u rning, mobilization, and
wound care). In contrast, the part
of the cost for nursing time in the
technical approach was €7 . 2 5
(55.9%). 
Cost of tre a t m e n t . The same
i n t e rvention (repositioning, mobi-
* Cost of repositioning is higher due to higher nurse salary during night shift.
NA = not applicabl e
Table 5.
Mean Cost per Intervention (Prevention) 
Mean Nursing Time in
M i nutes (95% CI)
Mean Cost per 
M i nute in  €*
Mean Cost per 
I n t e rvention in €
R e p o s i t i o n i n g 7.9 (7.3-8.6) 0 . 5 8 4 . 6 0
M o b i l i z a t i o n 8.0 (7.1-8.9) 0 . 4 7 3.75 
O i n t m e n t 2.5 (2.2-2.7) 0 . 4 7 1.16 
M a t t r e s s e s N A N A 5 . 6 7
Figure 2.



















* M a t t r e s s, pillow, special bed, ointment, bandages, ex t ra nu t rition, enteral nu t ri t i o n ,
heel preve n t i o n
† Mean cost per day in Euros (95% CI)
NT = nursing time
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lization) is more expensive in the
t reatment group than in the pre-
vention group as it takes more
nursing time to perf o rm the inter-
vention in patients with pre s s u re
ulcers (see Table 6).
The cost per day for pre s s u re
ulcer treatment is directly related to
the severity of the skin disord e r.
Table 7 shows the estimated budget
impact per pre s s u re ulcer grade for
the SAH with the pre d o m i n a n t l y
technical approach and the CWZ
with the predominantly human
a p p roach. Figure 3 shows that in
the human approach the major part
of the cost for treatment per grade
consisted of cost for nursing time,
w h e re in the technical approach the
majority consisted of cost for
re s o u rces. 
Cost per patient by hospital.
Although the length of stay in the
CWZ was significantly longer than
in the SAH (19.8 days vs. 16.4 days,
respectively), the patients in the
SAH had a higher risk for pre s s u re
ulcer development (see Table 1).
Also the mean number of days of
p revention was significantly higher
in the CWZ than in the SAH (13.4
days vs. 10.7 days, re s p e c t i v e l y ) .
Since the mean length of pre-
ventive care in the SAH is €1 0 . 7
days, budget impact for giving pre-
ventive care with a pre d o m i n a n t
focus on the technical appro a c h
rather than the human approach is
estimated at €139 (95% CI: €8 6 -
€193) per patient receiving pre v e n-
tion. The costs associated with pre-
vention with a predominant focus
on the human approach rather than
the technical approach were esti-
mated at €321 (95% CI: €2 2 8 -€4 0 2 )
per patient receiving pre v e n t i o n
(mean length of preventive care in
CWZ: 13.4 days).
The mean duration of tre a t-
ment per grade in the SAH varied
between 9 and 13 days, and in the
CWZ between 10 and 14 days (see
Table 7). The mean cost per grade
for giving treatment with a pre d o m-
inant focus on the technical
a p p roach rather than the human
a p p roach increased from €4 2 3
* Cost of repositioning is higher due to higher nurse salary during night shift.
NA = not applicabl e
Table 6.
Mean Cost per Intervention (Treatment)
Mean Nursing Time in
M i nutes (95% CI)
Mean Cost per 
M i nute in  €*
Mean Cost per 
I n t e rvention in € (95% CI)
R e p o s i t i o n i n g 10.4 (9.6 - 11.1) 0 . 5 8 6 . 0 0
M o b i l i z a t i o n 13.5 (11.9 -  5) 0 . 4 7 6 . 3 2
O i n t m e n t 2.6 (2.1 -  3.1) 0 . 4 7 1 . 2 2
Wound care 12.6 (10.4 - 14.8) 0 . 4 7 5 . 9 3
Wound care products N A N A 9 . 6 5
M a t t r e s s e s N A N A 1 1 . 2 0
* Based on data from Purse Value study. † In this study no grade IV ulcers occurred. We assumed that the number of treatment
d ays for grade IV is equal to the number of treatment days for grade III.
SAH = St. Antonius Hospital; CWZ = Canisius Wilhelmina Hospital 
Table 7.
Estimated Mean Cost of Pressure Ulcers in Euros per Grade per Hospital 
Cost per Day (95% CI) Mean Days of Treatment *
Mean Treatment Cost 
per Grade (95% CI)
S A H C W Z S A H C W Z S A H C W Z
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(95% CI: €1 6 2 -€675) per patient
with a grade 1 pre s s u re ulcer to
€1,287 (95% CI: €9 6 2 -€1,599) per
patient with a grade 4 pre s s u re
u l c e r. The mean cost per grade for
giving treatment with a pre d o m i-
nant focus on the human appro a c h
rather than the technical appro a c h
i n c reases from €352 (95% CI: €1 8 7 -
€528) per patient with a grade 1
p re s s u re ulcer to €1,722 (95% CI:
€1 , 0 5 0 -€2,394) per patient with a
grade 4 pre s s u re ulcer (see Table 7). 
The estimated budget impact of
t reatment per hospital cannot be
calculated as we did not have data
on the prevalence per grade fro m
the Purse Value study. 
National costs. The annual
number of hospital admissions in
the Netherlands in 2005 excluding
same day care admissions (<24-
hour stay) amounted to appro x i-
mately 1,650,000. About 30% of
these admissions (495,000) lasted
m o re than 5 days (CBS, 2008).
When using a validated risk assess-
ment scale, 40% of these patients
(198,000) were assessed to be in
need of preventive measures. This
number multiplied by the average
cost for prevention per patient
resulted in an estimate of the annu-
al burden for the Dutch national
health system of €27.5 million per
year when the focus would primari-
ly remain on a technical pre v e n t i o n
a p p roach, and an estimated €6 3 . 6
million per year if the focus was
primarily on a human pre v e n t i o n
a p p roach. 
The annual Dutch pre v a l e n c e
study showed a prevalence of 18%
of pre s s u re ulcers in Dutch hospi-
tals in 2006, with a subdivision of
10.3% for grade I pre s s u re ulcers,
5% for grade II, 2.4% for grade III,
and grade 0.8% for grade IV
(Halfens et al., 2006). A pro p o rt i o n-
al cost calculation for tre a t m e n t
resulted in an estimation of €1 7 8 . 8
million per year when the focus
would primarily be on a technical
a p p roach and an estimate of €1 7 4 . 5
million per year if the focus would
primarily be on a human appro a c h .
Adding prevention and tre a t m e n t
together leads to an estimated
national annual expenditure be-
tween €206.3 million and €2 3 8 . 1
million for pre s s u re ulcer care in
Dutch hospitals.
Cost minimization analysis.
The national cost for pre s s u re ulcer
p revention when the focus is pri-
marily on a technical pre v e n t i o n
a p p roach is significantly lower
than the national cost for pre s s u re
ulcer prevention when the focus is
primarily on a human pre v e n t i o n
a p p roach (€27.5 million [95% CI:
€17.0 million-€38.2 million] vs.
€63.6 million [95% CI: €45.1 mil-
l i o n -€79.6 million], p= 0 . 0 0 0 1 ) .
We do not have data on the
e ffectiveness of the treatment on
p re s s u re ulcer healing. This makes
it impossible to do a cost minimiza-
tion analysis on the treatment data.
Scenario analyses. Table 8
shows the variation in cost in the
d i ff e rent scenarios. The effect of
i n c reasing or decreasing the cost of
nursing has the largest impact on
the human approach (+/- 35%).
I n c reasing or decreasing the cost of
material has the largest impact on




















€1 2 3 †
* M a t t r e s s, pillow, special bed, ointment, bandages, ex t ra nu t rition, enteral nu t ri t i o n ,
heel preve n t i o n
† Mean cost per day in Euros
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D i s c u s s i o n
Both the technical and human pre s s u re ulcer pre v e n t i o n
strategy resulted in an incidence which did not differ signif-
i c a n t l y. However, a technical approach in pre s s u re ulcer pre-
vention is associated with lower cost than a human
a p p ro a c h .
The two hospitals diff e red in their preventive strategies.
The main focus of SAH appeared to be on technical support
(e.g., mattresses and dressings and ointments), while the
main focus of CWZ appeared to be on human support (e.g.,
repositioning and mobilization). Both approaches are in
a c c o rdance with the national pre s s u re ulcer guidelines
(CBO, 2002), and appear equally effective in preventing pre s-
s u re ulcers as the incidence of pre s s u re ulcers is low and
does not diff e r. These results are consistent with other stud-
ies. Va n d e rwee, Grypdonck, and Defloor (2005) re p o rted that
patients who were placed on an alternating mattress (techni-
cal approach) did not develop pre s s u re ulcers grade II or
worse more frequently than patients who underwent posi-
tion change every 4 hours on a visco-elastic foam mattre s s
(human approach). Bennett et al. (2004) also found that most
of the costs incurred for pre s s u re ulcers were due to nursing
time. While the CWZ also combined repositioning with the
use of special mattresses in their prevention strategy, the dif-
f e rences in costs between the two approaches in this study
a re striking. The daily cost of the human approach is two
times higher than the cost of the technical appro a c h .
T h e re f o re, we assume that in prevention of pre s s u re ulcers a
technical approach (a less labor-intensive approach) is pro b-
ably cost saving. 
Since we did not ascertain followup on the patients that
actually underwent treatment for pre s s u re ulcers, we have no
data on the effectiveness of the treatment and there f o re, we
cannot draw concrete conclusions re g a rding the cost eff e c-
tiveness of treatment strategies. However, the treatment cost
for more serious pre s s u re ulcers via the technical appro a c h
also appeared less expensive than the human appro a c h .
C o n v e r s e l y, this is not true for the less serious pre s s u re ulcers
(grade I and grade II). In the less serious pre s s u re ulcers the
material used in the predominantly technical approach is
expensive compared to the nursing time used in the pre d o m-
inantly human approach. 
It should be emphasized that the calculated costs re p re-
sent non-complicated pre s s u re ulcers. The annual figure s
mentioned are based on calculations of the mean. It is obvi-
ous that the costs for patients who need specialized tre a t-
ment for complicated pre s s u re ulcers (e.g., necrotomy or flap
s u rg e ry), will be much higher than the mean figures. These
t reatments are indicated for the more serious wounds (grade
III and grade IV pre s s u re ulcers). We recognize that the cost
of treatment of these wounds is under- re p resented and there-
f o re underestimated in this study. However, the vast majori-
ty of pre s s u re ulcers remain below grade IV and this study
t h e re f o re adequately reflects the overall budget impacts of in-
hospital pre s s u re ulcers.
N o t a b l y, the calculations are limited to Dutch hospitals.
In fact, the pre s s u re ulcer problem is far more extended, as it
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is not limited to hospitals alone
(Health Council of the Netherlands,
1999). Home care and nursing
home care costs were not taken into
account. 
In this study, we calculated the
amount of prevention days using
data from the Purse Value study.
This study was based on patients
who were expected to stay in the
hospital for more than 5 days. One
may argue that this leads to an over-
estimation of the cost, especially
p revention cost. However, in prac-
tice a risk assessment scale is not
used selectively (only for patients
who will be admitted for a longer
period of time). The risk assessment
will be made for all patients. It is,
h o w e v e r, not likely that this will
result in more patients at risk as the
patients who are admitted for less
than 5 days are generally in a better
condition or admitted for less
s e v e re treatments than patients
who need to stay more than 5 days.
T h e re f o re, we believe that this
selection did not result in a major
o v e restimation of the cost of pre-
vention when perf o rmed accord i n g
to the guideline. However, in prac-
tice the nurses may have concern s
about the validity of the outcome
on the risk assessment scale and
p rovide care based on their clinical
judgement. This will result in
patients at risk according to the risk
assessment scale not receiving pre-
ventive care, but also in patients not
at risk according to the risk assess-
ment scale receiving pre v e n t i v e
c a re. This will most probably re s u l t
in fewer patients receiving pre v e n-
tive care. The estimated cost of
p re s s u re ulcer prevention may
t h e re f o re be an overestimation of
the true cost due to nonadhere n c e
to the guideline. 
In clinical practice several risk
assessment scales are in use. The
scenario analysis based on the per-
centage of patients at risk shows
that the costs differ considerably
based on the risk assessment scale
used. Unfortunately these risk
assessment scales also differ in
their ability to detect patients at risk
for pre s s u re ulcers (Schoonhoven et
al., 2002). Thus it is reasonable to
assume that the incidence of pre s-
s u re ulcers will also vary depend-
ing on the risk assessment scale
used. As these data are not avail-
able, this could not be taken into
account in the various scenarios. 
F i n a l l y, one may argue that the
patient population in the two hos-
pitals is diff e rent. Although both
a re large teaching hospitals, the
length of stay and risk profile are
significantly diff e rent. SAH has a
s t rong focus on cardiothoracic sur-
g e ry, which may explain why more
patients are considered at risk.
Whether the diff e rences in patient
population can explain the diff e r-
ences in preventive approach is
c u rrently not known. 
Using a validated risk assess-
ment as an indicator for start i n g
p revention (Schoonhoven et al.,
2006) will result in identifying
a p p roximately 40% of the patients
as being at risk for pre s s u re ulcer
development and thus in need of
p reventive measures. Despite the
fact that the technical appro a c h
may decrease daily costs, almost
half of the patients will be in need
of prevention. Intere s t i n g l y,
Va n d e rwee et al. (2005) found that
postponing prevention until non-
blanchable erythema occurred did
not lead to a higher incidence of
p re s s u re ulcers grade II or worse.
This selective approach may fur-
ther decrease the cost of pre v e n t i v e
strategies. 
Assuming that pre v e n t i o n
would be implemented accord i n g
to the guideline would imply annu-
al expenditures between €2 0 6 . 3
million to €238.1 million for pre s-
s u re ulcers. Clearly, this disorder is
a major burden in terms of utiliza-
tion of health care re s o u rces and
personnel. The total health care
e x p e n d i t u re in the Netherlands for
hospital care in 2005 was appro x i-
mately €17 billion (CBS, 2008),
which means that between 1.21%
and 1.41% of the total budget is
spent on pre s s u re ulcer care in hos-
pitals alone. This is more than pre-
vious estimates (Severens et al.,
2002). 
C o n c l u s i o n
P re s s u re ulcers have a consid-
erable budget impact. The daily
cost of a technical approach in pre-
vention and treatment appears to be
lower than the cost of a human
a p p roach, specifically for higher-
grade pre s s u re ulcers. Changing
risk assessment and tre a t m e n t
strategies may further improve cost
e ffectiveness. However, there is an
u rgent need for large experimental
studies to further examine health
outcomes and cost effectiveness of
p revention and treatment of pre s-
s u re ulcers. $
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